discrete-event simulation in clinical trials - Institut für Statistik ...
discrete-event simulation in clinical trials - Institut für Statistik ...
discrete-event simulation in clinical trials - Institut für Statistik ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ABSTRACT<br />
The possibility of perform<strong>in</strong>g complete <strong>simulation</strong>s of<br />
cl<strong>in</strong>ical <strong>trials</strong>, based on pharmacological action models, has<br />
been considered s<strong>in</strong>ce the advent of the computer era, as<br />
a tool to optimize their practical realisation. Thanks to the<br />
advances <strong>in</strong> computation technology and <strong>in</strong> <strong>discrete</strong> <strong>event</strong><br />
<strong>simulation</strong> tools, today it is possible to perform realistic,<br />
large-scale cl<strong>in</strong>ical trial <strong>simulation</strong>s <strong>in</strong> a regular basis us<strong>in</strong>g<br />
suitable tools of <strong>simulation</strong>.<br />
In this sem<strong>in</strong>ar, we illustrate the process of construct<strong>in</strong>g<br />
realistic <strong>simulation</strong> models based <strong>in</strong> l<strong>in</strong>ear and non-l<strong>in</strong>ear<br />
mixed models us<strong>in</strong>g SAS and the LeanSim framework.<br />
LeanSim is an object-oriented general purpose <strong>simulation</strong><br />
tool, developed <strong>in</strong> C/C++, with a process-<strong>in</strong>teraction<br />
modell<strong>in</strong>g approach. These characteristics of LeanSim<br />
make it very flexible, facilitat<strong>in</strong>g its adaptation to simulate<br />
cl<strong>in</strong>ical <strong>trials</strong>.<br />
Some cl<strong>in</strong>ical <strong>trials</strong> (repeated measures designs) will be<br />
simulated and a methodology to build models of cl<strong>in</strong>ical<br />
<strong>trials</strong> and to simulate, validate and verify statistically them<br />
will be shown. A second part of the talk will be centered <strong>in</strong><br />
the statistical and data analysis facets of model validation<br />
and verification, based on the porcentage variation of<br />
likelihood criteria, compar<strong>in</strong>g the conceptual model and the<br />
<strong>simulation</strong> replications. A last and very <strong>in</strong>complete, for the<br />
moment, part of this research is centered <strong>in</strong> the use of<br />
Bayesian <strong>in</strong>ference to predict the behaviour of drugs <strong>in</strong> the<br />
organism of a new patient, based <strong>in</strong> a population model.<br />
2